Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    10671580 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Recombinant Human Adenovirus Type 5 Injection;   Procedure: Transartery Chemoembolization

Study has passed its completion date and status has not been verified in more than two years.